Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies

BACKGROUND & AIMS: Hepatitis C virus (HCV) has high genetic diversity with six major genotypes (GT) GT1‐6 and global distribution. HCV GT5 and 6 are rare with < 10 million people infected worldwide. Data on direct‐acting antiviral use in these rare HCV genotypes are limited. The study aimed t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Liver Int
Autori principali: Yao, Betty B., Fredrick, Linda M., Schnell, Gretja, Kowdley, Kris V., Kwo, Paul Y., Poordad, Fred, Nguyen, Kinh, Lee, Samuel S., George, Christophe, Wong, Florence, Gane, Edward, Abergel, Armand, Spearman, Catherine W., Nguyen, Tuan, Hung Le, Manh, Pham, Thuy TT., Mensa, Federico, Asselah, Tarik
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Viral Hepatitis
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539968/
https://ncbi.nlm.nih.gov/pubmed/32445613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14535
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi